Natco Pharma announces a total investment of $25 million in eGenesis through its subsidiaries.
According to The Hindu Business, Natco Pharma announces a total investment of $25 million in eGenesis through its subsidiaries. The Canadian subsidiary will invest $13.7 million, while Natco Pharma USA LLC will contribute $3 million.
Key facts
- 01Natco Pharma’s Canadian subsidiary will invest $13.7 million in eGenesis.
- 02Natco Pharma USA LLC will invest $3 million in eGenesis.
- 03The investment is described as a total of $25 million through Natco Pharma’s subsidiaries.
- 04The report is attributed to The Hindu Business.
AI-generated from the sources below. Always check the originals.
How each country tells it
So far our sources show coverage from one country. Perspectives appear once we find reports from a second country.
Sources
Summaries are AI-generated from the linked sources and may contain errors; always check the originals. We summarise and link; we never republish articles. Photos come from openly licensed libraries, official publicity material and brand logos, credited to their sources. If you own an image and want it credited differently or removed, email info@coda.news and we will act promptly.
- Natco Pharma to enhance total investment in eGenesis to $25 million · The Hindu Business